1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797633848026071040 |
|---|---|
| author | Jarushka Naidoo Igor Puzanov Jair Bar Niels Reinmuth Alona Zer Michal Harel Adam Dicker Michal Lotem Anirban Chatterjee Mahmoud Abu-Amna Mor Moskovitz Adam Hassani Itamar Sela Yehonatan Elon Iris Kamer Adva Levy-Barda Abed Agbarya Ina Koch David Farrugia Gillian Price Tatiana Harkovsky Rivka Katzenelson Ben Yelin Raya Leibowitz |
| author_facet | Jarushka Naidoo Igor Puzanov Jair Bar Niels Reinmuth Alona Zer Michal Harel Adam Dicker Michal Lotem Anirban Chatterjee Mahmoud Abu-Amna Mor Moskovitz Adam Hassani Itamar Sela Yehonatan Elon Iris Kamer Adva Levy-Barda Abed Agbarya Ina Koch David Farrugia Gillian Price Tatiana Harkovsky Rivka Katzenelson Ben Yelin Raya Leibowitz |
| author_sort | Jarushka Naidoo |
| collection | DOAJ |
| first_indexed | 2024-03-11T12:00:23Z |
| format | Article |
| id | doaj.art-0e3e42ead80141f4b5b96a3923da8e1d |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T12:00:23Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-0e3e42ead80141f4b5b96a3923da8e1d2023-11-08T07:20:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12291229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancerJarushka Naidoo0Igor Puzanov1Jair Bar2Niels Reinmuth3Alona Zer4Michal Harel5Adam Dicker6Michal Lotem7Anirban Chatterjee8Mahmoud Abu-Amna9Mor Moskovitz10Adam Hassani11Itamar Sela12Yehonatan Elon13Iris Kamer14Adva Levy-Barda15Abed Agbarya16Ina Koch17David Farrugia18Gillian Price19Tatiana Harkovsky20Rivka Katzenelson21Ben Yelin22Raya Leibowitz231Beaumont RCSI Cancer Centre, Dublin, Ireland3Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA2 Thoracic Oncology Unit, Institute of Oncology, Tel HaShomer Hospital, Tel Hashomer, Israel4Asklepios Lung Clinic, Munich-Gauting, Germany9Rambam Health Care Campus, Haifa, IsraelOncoHost LTD, Binyamina, Israel3Thomas Jefferson University, Philadelphia, PA, USASharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel17The Shrewsbury and Telford Hospital, Shrewsbury, UKRambam Health Care, Haifa, IsraelThoracic Cancer Service, Rambam Health Care Campus, Haifa, Israelacademic F1 doctor1Oncohost LTD, Binyamina, Israel18OncoHost LTD, Binyamina, Israel2Chaim Sheba Medical Center, Ramat Gan, IsraelBiobank, Department of Pathology, Beilinson Hospital, Petah Tikva, Israel6 Bnai Zion Medical Center, Haifa, Israel5Asklepios Klinik Gauting GmbH, Munich-Gauting, Germany11Cheltenham General Hospital, Cheltenham, UK13Aberdeen Royal Infirmary Grampian NHS, Aberdeen, UK14Barzilai Medical Center, Ashkelon, Israel16Kaplan Medical Center, Rehovot, Israel18OncoHost LTD, Binyamina, Israel20Shamir Medical Center, Zerifin, Israel |
| spellingShingle | Jarushka Naidoo Igor Puzanov Jair Bar Niels Reinmuth Alona Zer Michal Harel Adam Dicker Michal Lotem Anirban Chatterjee Mahmoud Abu-Amna Mor Moskovitz Adam Hassani Itamar Sela Yehonatan Elon Iris Kamer Adva Levy-Barda Abed Agbarya Ina Koch David Farrugia Gillian Price Tatiana Harkovsky Rivka Katzenelson Ben Yelin Raya Leibowitz 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer Journal for ImmunoTherapy of Cancer |
| title | 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer |
| title_full | 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer |
| title_fullStr | 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer |
| title_full_unstemmed | 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer |
| title_short | 1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer |
| title_sort | 1229 pre treatment plasma proteomics based predictive biomarkers for immune related adverse events in non small cell lung cancer |
| work_keys_str_mv | AT jarushkanaidoo 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT igorpuzanov 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT jairbar 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT nielsreinmuth 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT alonazer 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT michalharel 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT adamdicker 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT michallotem 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT anirbanchatterjee 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT mahmoudabuamna 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT mormoskovitz 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT adamhassani 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT itamarsela 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT yehonatanelon 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT iriskamer 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT advalevybarda 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT abedagbarya 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT inakoch 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT davidfarrugia 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT gillianprice 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT tatianaharkovsky 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT rivkakatzenelson 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT benyelin 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer AT rayaleibowitz 1229pretreatmentplasmaproteomicsbasedpredictivebiomarkersforimmunerelatedadverseeventsinnonsmallcelllungcancer |